Q4 2023 Holdings
Filed 2024-02-14 | 111 holdings | $5.0B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Sinovac Biotech LTD(SVA) | SHS | P8696W104 | $340.0M | 2,718,735 | 6.8% |
| Biogen Inc(BIIB) | COM | 09062X103 | $214.2M | 827,600 | 4.3% |
| ELI Lilly & Co(LLY) | COM | 532457108 | $213.0M | 365,400 | 4.3% |
| Boston Scientific Corp(BSX) | COM | 101137107 | $191.2M | 3,306,800 | 3.8% |
| Intuitive Surgical Inc(ISRG) | COM NEW | 46120E602 | $168.3M | 499,000 | 3.4% |
| Edgewise Therapeutics Inc(EWTX) | COM | 28036F105 | $159.4M | 14,567,176 | 3.2% |
| Biomarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $151.5M | 1,571,410 | 3.0% |
| Rayzebio Inc | COM | 75525N107 | $147.0M | 2,365,213 | 2.9% |
| Enliven Therapeutics Inc(ELVN) | COM | 29337E102 | $124.5M | 8,998,338 | 2.5% |
| Springworks Therapeutics Inc | COM | 85205L107 | $117.5M | 3,219,359 | 2.3% |
| Merck & Co Inc(MRK) | COM | 58933Y105 | $115.0M | 1,055,000 | 2.3% |
| Ionis Pharmaceuticals Inc(IONS) | COM | 462222100 | $104.5M | 2,064,797 | 2.1% |
| Disc Medicine Inc(IRON) | COM | 254604101 | $98.3M | 1,702,237 | 2.0% |
| Gracell Biotechnologies Inc | SPONSORED ADS | 38406L103 | $93.5M | 9,308,726 | 1.9% |
| Tenet Healthcare Corp(THC) | COM NEW | 88033G407 | $92.5M | 1,224,400 | 1.8% |
| Evolent Health Inc(EVH) | CL A | 30050B101 | $90.7M | 2,746,532 | 1.8% |
| United Therapeutics Corp del(UTHR) | COM | 91307C102 | $84.9M | 386,100 | 1.7% |
| Xtant MED Hldgs Inc(XTNT) | COM NEW | 98420P308 | $82.6M | 73,114,592 | 1.6% |
| Stryker Corporation(SYK) | COM | 863667101 | $80.6M | 269,000 | 1.6% |
| Scholar Rock Hldg Corp(SRRK) | COM | 80706P103 | $79.8M | 4,245,000 | 1.6% |
| Thermo Fisher Scientific Inc(TMO) | COM | 883556102 | $76.3M | 143,800 | 1.5% |
| Verona Pharma PLC(VRNA) | SPONSORED ADS | 925050106 | $75.1M | 3,777,778 | 1.5% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $72.4M | 1,153,091 | 1.4% |
| Theseus Pharmaceuticals Inc | COM | 88369M101 | $71.7M | 17,713,600 | 1.4% |
| Vertex Pharmaceuticals Inc(VRTX) | COM | 92532F100 | $71.3M | 175,200 | 1.4% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $68.4M | 519,279 | 1.4% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $67.3M | 697,500 | 1.3% |
| Elevance Health Inc(ELV) | COM | 036752103 | $66.7M | 141,500 | 1.3% |
| Third Harmonic BIO Inc(THRD) | COM | 88427A107 | $63.4M | 5,779,071 | 1.3% |
| Natera Inc(NTRA) | COM | 632307104 | $59.8M | 954,481 | 1.2% |
| Crinetics Pharmaceuticals in(CRNX) | COM | 22663K107 | $59.3M | 1,667,360 | 1.2% |
| Apellis Pharmaceuticals Inc(APLS) | COM | 03753U106 | $55.2M | 922,200 | 1.1% |
| R1 RCM Inc(RCM1USD) | COM | 77634L105 | $50.8M | 4,803,200 | 1.0% |
| ARS Pharmaceuticals Inc(SPRY) | COM | 82835W108 | $50.6M | 9,240,887 | 1.0% |
| Keros Therapeutics Inc(KROS) | COM | 492327101 | $50.4M | 1,268,734 | 1.0% |
| Humana Inc(HUM) | COM | 444859102 | $50.3M | 109,900 | 1.0% |
| Terns Pharmaceuticals Inc(TERN) | COM | 880881107 | $49.4M | 7,619,135 | 1.0% |
| Alpine Immune Sciences Inc(NVLSEUR) | COM | 02083G100 | $48.3M | 2,535,245 | 1.0% |
| Si-Bone Inc(SIBN) | COM | 825704109 | $48.1M | 2,292,531 | 1.0% |
| Prelude Therapeutics Inc(PRLD) | COM | 74065P101 | $46.6M | 10,909,256 | 0.9% |
| ALX Oncology Hldgs Inc(ALXO) | COM | 00166B105 | $46.1M | 3,095,000 | 0.9% |
| Neuropace Inc(NPCE) | COM | 641288105 | $41.3M | 4,003,967 | 0.8% |
| Iovance Biotherapeutics Inc(IOVA) | COM | 462260100 | $38.3M | 4,707,458 | 0.8% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $37.8M | 1,749,000 | 0.8% |
| Icon PLC(ICLR) | SHS | G4705A100 | $37.4M | 132,200 | 0.7% |
| Unitedhealth Group Inc(UNH) | COM | 91324P102 | $36.9M | 70,000 | 0.7% |
| Ikena Oncology Inc | NONVOTING | 000000000 | $36.8M | 12,048,773 | 0.7% |
| Amgen Inc(AMGN) | COM | 031162100 | $36.7M | 127,300 | 0.7% |
| Apogee Therapeutics Inc(APGE) | COM | 03770N101 | $35.7M | 1,277,901 | 0.7% |
| Janux Therapeutics Inc(JANX) | COM | 47103J105 | $35.6M | 3,317,927 | 0.7% |